newsfilter
← Latest News
GlobeNewswire·

Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs

DOYLESTOWN, Pa., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (NASDAQ:APRE) ("Aprea", or the "Company"), a clinical-stage precision medicine oncology company focused on the discovery and